Leonard Braden Michael's Form 4 filing
Aclaris Therapeutics, Inc. (ACRS) · filed Jun 18, 2024
- Accession no.
- 0001373604-24-000037
- Filed
- Jun 18, 2024
- Trade date
- Jun 14-18, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $629.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leonard Braden MichaelCIK 0001373603 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2024 | Common Stock | PPurchaseAcquired | +345,000 | $1.17 | +$403,650 | 11,352,134 | Indirect | |
| Jun 17, 2024 | Common Stock | PPurchaseAcquired | +150,000 | $1.13 | +$169,500 | 11,502,134 | Indirect | |
| Jun 18, 2024 | Common Stock | PPurchaseAcquired | +50,000 | $1.13 | +$56,500 | 11,552,134 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.